US President Donald Trump’s latest announcement of 100% tariffs imported branded or patented pharmaceutical products has sent shockwaves through pharma companies around the world. Trump announced on Truth Social that effective October 1, 2025, a 100% tariff will be applicable on imported branded or patented pharmaceutical products entering the United States, with exemptions for manufacturers actively constructing drug-manufacturing facilities within US borders. “Starting October 1st, 2025, we will be imposing a 100% Tariff on any branded or patented Pharmaceutical Product, unless a Company IS BUILDING their Pharmaceutical Manufacturing Plant in America. “IS BUILDING” will be defined as, “breaking ground” and/or “under construction.” There will, therefore, be no Tariff on these Pharmac

See Full Page